Singapore, December 1, 2021 – Credo Diagnostics Biomedical Pte Ltd changes registered address to: 491B RIVER VALLEY ROAD, #06-01 VALLEY POINT, SINGAPORE (248373)
Credo Diagnostics Biomedical is pleased to announce the expansion of the QubeMDx+™ veterinary molecular diagnostics portfolio with four new assays designed to support the detection
At Credo Diagnostics Biomedical, we help partners transform innovative concepts into market-ready molecular diagnostic solutions. Backed by more than a decade of experience in molecular
Credo Diagnostics Biomedical is pleased to announce the expansion of the QubeMDx+™ veterinary molecular diagnostics portfolio with four new assays
At Credo Diagnostics Biomedical, we help partners transform innovative concepts into market-ready molecular diagnostic solutions. Backed by more than a
Rapid differentiation of respiratory pathogens remains one of the key challenges in clinical diagnostics. Because SARS-CoV-2, influenza viruses, and respiratory
In vet care, speed and accuracy save lives—no time to wait or guess. QubeMDx+™ delivers fast, lab quality PCR results
Can you handle your liquor effortlessly, or do you turn bright red after just one drink? Either way, it’s not
Focusing on research and development of revolutionary diagnostic technologies since 2011, Credo Diagnostics develops, manufactures, and commercializes accurate, rapid, and affordable molecular diagnostic solutions at the Point-Of-Care testing.
© 2023 | Credo Diagnostics Biomedical Pte. Ltd.
